SEC Form 4 · accession 0001127602-18-012824
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P King
Officer — President & CEO · Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 27, 2018 · 9:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2018 | M | 49,967 | $84.86 | A | 231,202 | D | |
| Common StockF2 | Mar 23, 2018 | S | 1,689 | $163.5805 | D | 229,513 | D | |
| Common StockF3 | Mar 23, 2018 | S | 36,265 | $164.5508 | D | 193,248 | D | |
| Common StockF4 | Mar 23, 2018 | S | 10,313 | $165.3891 | D | 182,935 | D | |
| Common StockF5 | Mar 23, 2018 | S | 1,700 | $166.3752 | D | 181,235 | D | |
| Common Stock | holding | — | — | — | 27,811 | I | By grantor retained annuity trust | |
| Common Stock | holding | — | — | — | 47,357 | I | By grantor retained annuity trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionsF6,F7 | $84.86 | Mar 23, 2018 | M | 49,967 | D | May 24, 2013 | May 23, 2022 | Common Stock | 49,967 | 99,933 | D |
Explanation of responses
- F1Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2The price of $163.5805 per share represents a weighted average of sales prices ranging from $162.96 to $163.865 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3The price of $164.5508 per share represents a weighted average of sales prices ranging from $163.995 to $164.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F4The price of $165.3891 per share represents a weighted average of sales prices ranging from $164.99 to $165.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5The price of $166.3752 per share represents a weighted average of sales prices ranging from $166.089 to $166.80 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F6Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- F7The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable.